UK markets closed

Alligator Bioscience AB (publ) (0RK9.L)

LSE - LSE Delayed price. Currency in SEK
Add to watchlist
1.1200-0.1220 (-9.82%)
At close: 08:35AM GMT
Currency in SEK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.35
52-week change 383.61%
S&P500 52-week change 327.86%
52-week high 31.5080
52-week low 30.0000
50-day moving average 30.6220
200-day moving average 30.6114

Share statistics

Avg vol (3-month) 324.49k
Avg vol (10-day) 327.24k
Shares outstanding 571.39M
Implied shares outstanding 6N/A
Float 8428.96M
% held by insiders 145.04%
% held by institutions 14.24%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-581.61%

Management effectiveness

Return on assets (ttm)-108.23%
Return on equity (ttm)-492.71%

Income statement

Revenue (ttm)59.25M
Revenue per share (ttm)0.13
Quarterly revenue growth (yoy)-41.10%
Gross profit (ttm)N/A
EBITDA -248.24M
Net income avi to common (ttm)-248.59M
Diluted EPS (ttm)-0.5960
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)66.12M
Total cash per share (mrq)0.1
Total debt (mrq)16.1M
Total debt/equity (mrq)135.78%
Current ratio (mrq)0.79
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-189.28M
Levered free cash flow (ttm)-100.16M